Skip to main content

Table 1 Characteristics of patients

From: Mutation analysis of BCR-ABL1 kinase domain in chronic myeloid leukemia patients with tyrosine kinase inhibitors resistance: a Malaysian cohort study

Characteristics

TKI resistant patients

(n = 84)

Patients with optimal response (n = 18)

Median age, years

46 (15–72)

55 (19–65)

Gender, n (%)

  

 Male

46 (54.8)

11 (61.1)

 Female

38 (45.2)

7 (38.9)

Race, n (%)

  

 Malay

49 (58.3)

13 (72.2)

 Chinese

17 (20.2)

4 (22.2)

 Indian

14 (16.7)

0 (0)

 Others

4 (4.8)

1 (5.6)

CML phase, n (%)

  

 Chronic phase

56 (66.7)

18 (100)

 Accelerated phase

18 (21.4)

0 (0)

 Blast phase

10 (11.9)

0 (0)